Your browser doesn't support javascript.
loading
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy.
Montopoli, M; Zorzi, M; Cocetta, V; Prayer-Galetti, T; Guzzinati, S; Bovo, E; Rugge, M; Calcinotto, A.
Afiliação
  • Montopoli M; Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy; VIMM-Veneto Institute of Molecular Medicine, Fondazione per la Ricerca Biomedica Avanzata, Padova, Italy; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bell
  • Zorzi M; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Cocetta V; Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy.
  • Prayer-Galetti T; Department of Oncological and Gastroenterological Sciences-Urology Unit, Azienda Ospedaliera di Padova, Padova, Italy.
  • Guzzinati S; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Bovo E; Veneto Tumour Registry, Azienda Zero, Padova, Italy.
  • Rugge M; Veneto Tumour Registry, Azienda Zero, Padova, Italy; Department of Medicine, Università degli Studi di Padova, Padova, Italy. Electronic address: massimo.rugge@unipd.it.
  • Calcinotto A; Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Università della Svizzera Italiana, Lugano, Switzerland. Electronic address: arianna.calcinotto@ior.usi.ch.
Ann Oncol ; 32(5): 676-677, 2021 05.
Article em En | MEDLINE | ID: mdl-33524477

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / COVID-19 Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias da Mama / COVID-19 Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article